ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging
Authors:
- 6 March 2012
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 33 (3) , 669-677
Abstract
Combining the specificity of tumor-targeting antibodies with the sensitivity and quantification offered by positron emission tomography (PET) provides tremendous opportunities for molecular characterization of tumors in vivo. Until recently, significant challenges have been faced when attempting to combine antibodies which show long biological half-lives and positron-emitting radionuclides with comparably short physical half-lives, in particular 18F (half-life, 109 min). A fast and simple microwave-assisted method of generating N-succinimidyl-4-[18F]fluorobenzoate has been developed and employed for radiolabeling a small, rapidly targeting HER2-specific engineered antibody fragment, the cys-diabody. Using this tracer, HER2-positive tumor xenografts in mice were detected at 1–4 h post-injection by microPET. This confirms the rapid kinetics of [18F]fluorobenzoyl cys-diabody localization, and demonstrates the feasibility of same-day immunoPET imaging. This approach can be broadly applied to antibodies targeting cell surface biomarkers for molecular imaging of tumors and should be highly translatable for clinical use.Keywords
This publication has 35 references indexed in Scilit:
- Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)Journal of Visualized Experiments, 2011
- Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody MoleculesJournal of Nuclear Medicine, 2010
- Antibody Vectors for ImagingSeminars in Nuclear Medicine, 2010
- A Novel Method of 18F Radiolabeling for PETJournal of Nuclear Medicine, 2009
- Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with Site-Specific 18F-Labeled Protein Scaffold MoleculesJournal of Nuclear Medicine, 2008
- [18F]FBEM-ZHER2:342-Affibody molecule—a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cellsOncogene, 1999
- Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applicationsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.1995
- Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography.1992